KLRS · Categories · Form 4
KLRS - SEC Form 4 insider transactions
Kalaris Therapeutics Inc. (KLRS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for KLRS
- SEC Form 4 filed by Hagen Brett R4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Oxtoby Andrew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Gall Matthew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Feinsod Matthew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- Director Akkaraju Srinivas was granted 1,500,000 shares (SEC Form 4)4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Gall Matthew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Patel Samir Chandrakant4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Jovan-Embiricos Morana4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Akkaraju Srinivas4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Chief Accounting Officer Hagen Brett R4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Ferrara Napoleone4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Officer Oxtoby Andrew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Adamis Anthony P4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Feinsod Matthew4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Patterson Leone D4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)
- SEC Form 4 filed by Director Hallal David4 - Kalaris Therapeutics, Inc. (0001754068) (Issuer)